The first clinical trial of the Oxford team’s penicillin treatment took place in 1941. On 12 February, physician Charles Fletcher administered penicillin to Albert Alexander, a police constable suffering from a severe bacterial infection.
Alexander’s infection had spread across his face and involved both staphylococci and streptococci. His condition improved dramatically after treatment: his fever fell, his appetite returned, and the infection began to retreat. However, the researchers had only a small supply of penicillin.
When the medicine ran out, Alexander relapsed and died in March 1941. The disappointing outcome exposed the central problem facing the Oxford researchers: their laboratory could demonstrate penicillin’s power, but could not yet manufacture enough of it for sustained treatment.
The year can be confused with 1930, when Cecil Paine used a crude penicillin preparation to treat eye infections in infants, or with 1942, when US-produced penicillin entered an important American clinical trial. In the standard account of penicillin’s first clinical trial, the answer is 1941.